We use cookies so we can provide you with the best online experience. By continuing to browse this site you are agreeing to our use of cookies. Click on the banner to find out more.
Cancer experts have reported future trends and progress in radiotherapy treatments for lung cancer using motion management and tumour-tracking technologies from Varian Medical Systems at the annual ESTRO Forum (19–23 April 2013, Geneva, Switzerland). read more
Better outcomes can be achieved for prostate cancer patients using brachytherapy, a highly targeted form of radiotherapy, compared to surgery according to study findings conducted by Panaxea, The University of Twente, The Netherlands. read more
Elekta recently received 510(k) clearance from the US Food and Drug Administration (FDA) which allows the company to begin shipping and installation of all components of the Versa HD system within the USA. read more
Hudayi Korkusuz, Hospital of Johann Wolfgang Goethe University, Frankfurt, Germany, has conducted the first combination treatment of microwave ablation and radiotherapy, according to a press release. read more
On 11–12 April, Nordion will host its 3rd European TheraSphere User Group Meeting in Vienna, Austria, and on 18 April, Nordion will offer a Satellite Symposium at the 3rd Interdisciplinary Treatment of Liver Tumors (ITLT) Meeting in Essen, Germany, according to a company release. read more
BSD Medical announced today that the company has signed an exclusive, long-term, multi-million dollar distribution agreement with Terumo Europe, a wholly owned subsidiary of Terumo Corporation, for the MicroThermX Microwave Ablation System. read more
Nordion a leading provider of products and services for the prevention, diagnosis and treatment of disease, will host an educational session called “TheraSphere test flight interactive: How to treat or should I treat?” at the Society for Interventional Radiology’s (SIR) Annual Scientific Meeting (13–18 April, New Orleans, USA). read more
Portable Medical, according to the company website, has received the CE mark for its oncology decision-making smartphone app—ONCOassist. The app was developed in conjunction with doctors and is classed as a medical device in accordance with EU regulations. read more
Boston Scientific announced it is supporting Colorectal Cancer Awareness Month with a range of awareness-raising activities throughout March. read more
